Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sulfated cell-surface proteoglycans, most notably heparan sulfate proteoglycans (HSPGs) such as syndecans and glypicans, are complex glycoproteins characterized by a core protein attached to sulfated glycosaminoglycan (GAG) chains. These molecules are ubiquitous on the plasma membrane of animal cells, where they serve as critical regulators of the cellular microenvironment by binding a vast array of ligands, including growth factors, cytokines, and extracellular matrix proteins (Sarrazin et al., 2011, Cold Spring Harb Perspect Biol). By acting as co-receptors, they facilitate the formation of signaling complexes, thereby modulating pathways involved in cell proliferation, migration, and differentiation. In the context of infectious disease, many viruses and bacteria utilize these sulfated chains as initial attachment factors to concentrate on the cell surface before engaging specific entry receptors (Clausen et al., 2020, Cell). In oncology, dysregulation of these proteoglycans or their modifying enzymes, such as heparanase, promotes tumor angiogenesis and metastasis by releasing sequestered growth factors (Knelson et al., 2014, Nat Rev Cancer). Consequently, they are targeted by heparin mimetics and small molecules designed to disrupt these interactions or inhibit their degradation, offering therapeutic potential in cancer and viral infections (Hammond et al., 2014, Glycobiology).
Competitive inhibition of ligand binding to glycosaminoglycan chains and inhibition of heparanase-mediated degradation of the extracellular matrix.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sulfated cell-surface proteoglycan (HSPG).